Rank #1248INSM

Insmed Incorporated

$161.00

6.54% (Daily)

Market Cap

$34.34B

Revenue

$447.02M

Rank by MCap

#1248

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. William H. Lewis J.D., M.B.A.

Headquarters

Bridgewater, NJ

Employees

1,271

About Insmed Incorporated

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor...